Ordinary Annual General Meeting 2026

The Annual General Meeting of Evotec SE will be held on Thursday, 11 June 2026, 10:00 a.m. (CEST), at the CinemaxX Hamburg-Dammtor, Saal 1, Dammtordamm 1, 20354 Hamburg, Germany as an in-person event. 

If you wish to view our Annual General Meeting archive you can do so here.

Agenda

  1. Presentation of the approved annual financial statements and the consolidated financial statements of Evotec SE as of 31 December 2025, as approved by the Supervisory Board, the management reports for Evotec SE and the Group for the financial year 2025, the report of the Supervisory Board for the financial year 2025 and the comments by the Management Board regarding this information pursuant to Sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch, HGB).
  2. Resolution discharging the members of the Management Board of liability for financial year 2025.
  3. Resolution discharging the members of the Supervisory Board of liability for financial year 2025.
  4. Resolution regarding the election of the auditor of the consolidated financial statements and the auditor of the sustainability report for financial year 2026 and of the auditor for any review of additional financial information during the year 
    4.1 Election of the auditor of the the consolidated financial statements and of the auditor for any review of additional financial information during the year
    4.2 Election of the auditor of the sustainability report
  5. Resolution to approve the Remuneration Report 2025
  6. Resolution on expanding the Supervisory Board and the corresponding amendment to Article 9 (1) of the Articles of Association
  7. Resolution on new and re-elections to the Supervisory Board
    7.1 Dr. Wolfgang Hofmann
    7.2 Dr Duncan McHale
    7.3 Dieter Weinand 
    7.4. Wesley Wheeler
  8. Resolution on creating contingent capital for the issue of subscription rights to Management Board members of Evotec SE, members of management boards of affiliated companies in Germany and abroad and selected managers of Evotec SE and affiliated companies in Germany and abroad as part of a Performance Share Plan 2026 (PSP 2026), based on a resolution of authorisation and amendments to the articles of association.
    a) Authorisation to issue stock options with subscription rights to Evotec SE shares
    b) Contingent capital
    c) Amendments to the Articles of Association
    d) Discontinuation of the Share Performance Programmes 2015 and 2017
  9. Resolution to approve the revised remuneration system for the Management Board

Convocation Documents for Download

Password-protected AGM Portal                                                                                                            

LOGIN to the password-protected AGM Portal  granting a power of attorney to a third person as well as for granting power of attorney and issuing instructions to the proxies appointed by the Company.

The personal access data required for this purpose will be sent to the shareholders or their proxies after registration for the Annual General Meeting. 
In case of later (sub-)authorisation, the following applies: The use of the password-protected AGM Portal by the proxy requires that the proxy receives the corresponding access data.

A power of attorney to a third person as well as a power of attorney with instructions to the proxies of the Company may be granted, amended or revoked via the password-protected AGM Portal until 24:00 (CEST) on 10 June 2026.

Proxy Voting

Further Downloads

Countermotions

Currently, there are no countermotions.
 

Confirmation of the vote count pursuant to section 129 (5) sentence 1 AktG:

Pursuant to section 129 (5) sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month of the day of the Annual General Meeting as to whether and how his or her vote was counted. A request to this effect may be sent by e-mail to: evotec@meet2vote.de 

 

Hotline

Monday to Friday from 9 am to 5 pm (except on holidays) 
by phone on +49 8561 9884721

 

Contact AGM Team

Evotec SE

Anja Ben Lekhal

Investor Relations

Manfred Eigen Campus

Essener Bogen 7

22419 Hamburg

T: +49 151 5187 1069

hauptversammlung@evotec.com 


 

Contact to the ADR Program

JPMorgan Chase & Co.

P.O. Box 64504

St. Paul, MN 55164-0504

USA

T: 800.990 1135 (from inside the USA)

T: +1.651.453 2128 (from outside the USA)

jpmorgan.adr@eq-us.com

Group of people sitting in chairs watching a presentation

Annual General Meeting Archive

World white

Investor Relations

vCard
Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.